Rachel Humphrey - Insider Trading & Ownership

Location
C/O Mirati Therapeutics Inc., 4660 La Jolla Village Drive, Suite 500, San Diego, CA
Summary
The estimated net worth of Rachel Humphrey is at least $44.1K dollars as of April 2, 2025. Rachel Humphrey is the Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $36.2K. Rachel Humphrey is the Director of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $7.84K.
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Rachel Humphrey
All Insider Reports
All Insider Reports

Ownership of Rachel Humphrey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PYXS Pyxis Oncology, Inc. Director $36.2K Mar 31, 2025
XLO Xilio Therapeutics, Inc. Director $7.84K Oct 21, 2021

Insider Transactions Reported by Rachel Humphrey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.